Related Experiment Video
Updated: May 24, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Protease inhibitor monotherapy: what is its role?
Miriam Estébanez1, Jose R Arribas
1Servicio de Medicina Interna, Unidad VIH Hospital La Paz, IdiPAZ, Madrid, Spain.
Current HIV/AIDS Reports
|February 25, 2012
Summary
Protease inhibitor monotherapy effectively suppresses viruses and may improve body fat and bone health. However, potential risks like neurological events and inflammation require further investigation for long-term patient safety.
Area of Science:
- Infectious Diseases
- Pharmacology
- Virology
Background:
- Protease inhibitor monotherapy is effective for long-term viral suppression in many patients.
- Withdrawing nucleoside analogues can mitigate drug-related toxicities.
- Emerging data suggests benefits for body fat distribution and bone metabolism.
Purpose of the Study:
- To review the efficacy and safety of protease inhibitor monotherapy.
- To discuss potential benefits on body composition and bone health.
- To address uncertainties regarding neurological events and inflammation.
Main Methods:
- Review of clinical trial data.
- Analysis of preliminary study findings.
- Discussion of potential adverse events and uncertainties.
Main Results:
- Protease inhibitor monotherapy demonstrates efficacy in viral suppression.
- Preliminary data indicates positive effects on body fat distribution.
- Potential benefits on bone metabolism are suggested by recent trials.
Conclusions:
- Protease inhibitor monotherapy offers a viable strategy for viral suppression with potential metabolic benefits.
- Further research is needed to fully understand and manage risks, including neurological events and subclinical inflammation.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.